…esigned studies. To focus on the metastatic setting relevant to oligometastatic disease, trials referring to early-stage (stage I–II) or locally advanc…
non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning non-small cell lung cancer
126 articles · page 1 of 11…land during the pandemic.36 37 In the years following 2020, the lung cancer diagnoses have increased, but SACT treatment rates have been sl…
…ab to treat non-small cell lung cancer, and pemetrexed to treat non-small cell lung cancer) accounted for 68.4% (n=52 107 years) of the total life year ga…
…Int J Mol Med. 2021;48:214.Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin P…
…cines. 2023;11(2):508.Liu C, Huang Y, Cui Z, et al. KRAS-mutant non-small cell lung cancer: from molecular heterogeneity to clinical management. Cancer Co…
…xture.9–11 Methods CD8 immunohistochemistry was performed on 35 NSCLC whole-slide resection specimens and a corresponding TMA compris…
…roangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia. 2013;15:133-142.Brownlie D, von Kries A, Valenzano …
…apy has been tested in other solid tumour malignancies, such as renal cell carcinoma (29% ORR in 7 patients),49 non-small cell lung cancer (23% ORR …
…aortic blood poolAbstract 35 Figure 1Graphical abstract. NSCLC: Non-small cell lung cancer, PET: Positron Emission Tomography, CT: Computed Tomography, [1…
…performed a prospective study (n=113) in patients with advanced NSCLC treated with single agent ICIs and correlated clinopathological…
…ng a delay in surgery due to treatment-related toxicity, namely myositis. A pathological response was observed in 98% of patients, with …
…) for lung cancer, nine (10.0%) for leukaemia, eight (8.9%) for urothelial carcinoma, and six (6.7%) for breast cancer ( table 1, online supplementa…